Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug
about
Nanotechnology-based drug delivery systems for treatment of oral cancer: a reviewNanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutions.Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid.Cancer drug delivery in the nano era: An overview and perspectives (Review)Nanostructured lipid carriers employing polyphenols as promising anticancer agents: Quality by design (QbD) approach.Quercetin-imprinted nanospheres as novel drug delivery devicesBuparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases.Inhibition of Zymosan-Induced Inflammatory Factors Expression by ATRA Nanostructured Lipid Carriers.Nanostructured lipid carriers as a delivery system of biochanin A.Nanocarrier-mediated delivery of α-mangostin for non-surgical castration of male animals.All-trans retinoic acid-loaded lipid nanoparticles as a transdermal drug delivery carrier.An Abraded Surface of Doxorubicin-Loaded Surfactant-Containing Drug Delivery Systems Effectively Reduces the Survival of Carcinoma Cells.Zerumbone-Loaded Nanostructured Lipid Carrier Induces Apoptosis of Canine Mammary Adenocarcinoma CellsComparison of Apoptotic Inducing Effect of Zerumbone and Zerumbone-Loaded Nanostructured Lipid Carrier on Human Mammary Adenocarcinoma MDA-MB-231 Cell Line
P2860
Q26995835-64543AED-E132-47E4-B8CB-E580E6360F44Q33962553-CC73CBFA-9616-4ED3-BC5B-D331229EA43DQ36253332-611B8FB4-879B-45F0-8420-145E26D34F3CQ38669454-8FAB6A7A-63FF-4544-A057-4EE2C35C4714Q39305508-2AE0E8BB-15B5-4FAD-93E3-ADBD37C333BFQ40388738-09917A2F-356C-4D29-A3C7-10EC35A77624Q42321490-F7443349-ED37-4A1A-99E0-09A6517DBF6BQ42577077-BD472CD9-B357-4885-8A97-158C426FD651Q45415768-4971A83F-5991-42EB-8230-12D28E49C768Q47140533-0D700DD2-6D8F-45C9-A6EF-BCE99F5348BDQ50484785-D1EAC5DE-71DA-4755-B42D-B7D8B5CCB3E9Q50865516-BA4F74CC-619D-4800-A355-84A843C8F434Q58560822-93B32B95-9768-465C-BEE5-783C9F0ACF8DQ59059048-AB4F401F-732E-4A43-850C-747A09040DD1
P2860
Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug
@ast
Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug
@en
type
label
Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug
@ast
Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug
@en
prefLabel
Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug
@ast
Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug
@en
P2093
P2860
P1433
P1476
Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug
@en
P2093
Akhayacatra Chinsriwongkul
Ponwanit Chareanputtakhun
Praneet Opanasopit
Tanasait Ngawhirunpat
Theerasak Rojanarata
Uracha Ruktanonchai
Warisada Sila-on
P2860
P2888
P304
P356
10.1208/S12249-011-9733-8
P407
P577
2011-12-14T00:00:00Z
P5875
P6179
1014888752